Nemes Rush Group LLC Argenx Se Transaction History

Nemes Rush Group LLC

  • $689 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$356.95 - $413.29 $2,498 - $2,893
7 Added 25.0%
35 $13.8 Million
Q4 2023

Feb 09, 2024
BUY
$338.91 - $506.01 $2,711 - $4,048
8 Added 40.0%
28 $10.7 Million
Q3 2023

Nov 09, 2023
BUY
$369.35 - $548.43 $7,387 - $10,968
20 New
20 $9.83 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email